The Biotech Growth Trust PLC (LSE:BIOG) — Stock Price
The Biotech Growth Trust PLC (LSE:BIOG) is currently trading at GBX1696.00 GBX, up 0.24% today. Over the past 52 weeks, shares have ranged between GBX822.00 and GBX1696.00. This page tracks The Biotech Growth Trust PLC's live share price on the LSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see The Biotech Growth Trust PLC (BIOG) market capitalisation.
The Biotech Growth Trust PLC (BIOG) Stock Price Chart — Daily History & Trading Volume
The chart below tracks The Biotech Growth Trust PLC's daily closing share price and trading volume on the LSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
The Biotech Growth Trust PLC Income Statement — Revenue, Profit & Earnings by Year
The Biotech Growth Trust PLC's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | GBX-77.48 Million | GBX80.35 Million | GBX-37.65 Million | GBX-209.71 Million | GBX204.35 Million |
| Cost of Revenue | GBX1.32 Million | GBX2.35 Million | GBX5.31 Million | GBX4.80 Million | GBX-17.76 Million |
| Gross Profit | GBX-78.81 Million | GBX78.00 Million | GBX-42.97 Million | GBX-214.51 Million | GBX222.11 Million |
| Research & Development | — | — | — | — | — |
| SG&A | GBX3.62 Million | GBX3.17 Million | GBX3.52 Million | GBX3.22 Million | GBX3.73 Million |
| Total Operating Expenses | GBX3.71 Million | GBX3.24 Million | GBX3.59 Million | GBX-7.44 Million | GBX3.80 Million |
| Operating Income | GBX-82.52 Million | GBX76.50 Million | GBX-36.69 Million | GBX-199.75 Million | GBX197.34 Million |
| EBITDA | GBX-82.52 Million | GBX74.76 Million | GBX-5.34 Million | GBX-10.73 Million | GBX3.04 Million |
| EBIT | — | GBX151.25 Million | GBX-42.03 Million | GBX-210.48 Million | GBX200.38 Million |
| Interest Expense | GBX1.32 Million | GBX1.11 Million | GBX792.00K | GBX175.00K | GBX179.00K |
| Income Before Tax | GBX-82.52 Million | GBX74.76 Million | GBX-41.24 Million | GBX-202.27 Million | GBX200.56 Million |
| Income Tax Expense | GBX145.00K | GBX159.00K | GBX56.00K | GBX149.00K | GBX131.00K |
| Net Income | GBX-82.66 Million | GBX74.60 Million | GBX-41.30 Million | GBX-202.42 Million | GBX200.43 Million |
The Biotech Growth Trust PLC Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes The Biotech Growth Trust PLC's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | GBX226.63 Million | GBX411.42 Million | GBX360.51 Million | GBX427.45 Million | GBX649.53 Million |
| Total Current Assets | GBX8.47 Million | GBX16.67 Million | GBX3.28 Million | GBX49.00K | GBX6.26 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | — | GBX14.51 Million | GBX487.00K | GBX4.72 Million | GBX4.72 Million |
| Inventory | — | GBX0.00 | — | — | — |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | — | — | — | — | — |
| Total Liabilities | GBX5.42 Million | GBX50.11 Million | GBX30.22 Million | GBX33.24 Million | GBX48.06 Million |
| Total Current Liabilities | GBX405.00K | GBX52.52 Million | GBX30.22 Million | GBX33.24 Million | GBX48.06 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | GBX-8.45 Million | GBX44.95 Million | GBX17.40 Million | GBX31.74 Million | GBX25.28 Million |
| Total Stockholder Equity | GBX221.21 Million | GBX361.31 Million | GBX330.29 Million | GBX394.21 Million | GBX601.47 Million |
| Retained Earnings | — | GBX-965.00K | GBX-51.65 Million | GBX-108.59 Million | GBX78.26 Million |
The Biotech Growth Trust PLC Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how The Biotech Growth Trust PLC generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | GBX-5.09 Million | GBX-4.24 Million | GBX-5.89 Million | GBX-12.14 Million | GBX-5.67 Million |
| Capital Expenditures | GBX0.00 | GBX0.00 | GBX0.00 | GBX1.04 Million | GBX0.00 |
| Free Cash Flow | GBX-5.09 Million | GBX-4.24 Million | GBX-5.89 Million | GBX-13.19 Million | GBX-5.67 Million |
| Investing Cash Flow | GBX115.85 Million | GBX22.34 Million | GBX45.69 Million | GBX13.03 Million | GBX-25.55 Million |
| Financing Cash Flow | GBX-104.29 Million | GBX-18.74 Million | GBX-37.03 Million | GBX-2.39 Million | GBX32.73 Million |
| Dividends Paid | GBX0.00 | GBX0.00 | GBX0.00 | GBX0.00 | GBX0.00 |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | — | — | — | — | — |
| Change in Cash | GBX6.32 Million | GBX-641.00K | GBX2.77 Million | GBX-1.50 Million | GBX1.50 Million |
The Biotech Growth Trust PLC Earnings History — EPS Actual vs. Analyst Estimates
Track The Biotech Growth Trust PLC's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Nov 25, 2025 | 2.73 | — | — |
| Jun 04, 2025 | -3.01 | — | — |
| Nov 27, 2024 | 0.25 | 0.00 | — |
| Nov 16, 2022 | 0.91 | 0.00 | — |
| Jun 01, 2022 | -3.70 | 0.00 | — |
| Nov 11, 2021 | -1.20 | 0.00 | — |
| Jun 04, 2021 | 0.55 | 0.00 | — |
| Nov 16, 2020 | 4.53 | 0.00 | — |